Annual EBIT
-$7.10 M
-$2.67 M-60.29%
December 31, 2023
Summary
- As of February 7, 2025, GCTK annual earnings before interest & taxes is -$7.10 million, with the most recent change of -$2.67 million (-60.29%) on December 31, 2023.
- During the last 3 years, GCTK annual EBIT has fallen by -$3.97 million (-126.82%).
- GCTK annual EBIT is now -507.02% below its all-time high of -$1.17 million, reached on December 31, 2009.
Performance
GCTK EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$3.25 M
+$1.24 M+27.61%
September 30, 2024
Summary
- As of February 7, 2025, GCTK quarterly earnings before interest & taxes is -$3.25 million, with the most recent change of +$1.24 million (+27.61%) on September 30, 2024.
- Over the past year, GCTK quarterly EBIT has dropped by -$834.00 thousand (-34.51%).
- GCTK quarterly EBIT is now -554.52% below its all-time high of -$496.70 thousand, reached on June 30, 2011.
Performance
GCTK Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$13.11 M
-$1.03 M-8.50%
September 30, 2024
Summary
- As of February 7, 2025, GCTK TTM earnings before interest & taxes is -$13.11 million, with the most recent change of -$1.03 million (-8.50%) on September 30, 2024.
- Over the past year, GCTK TTM EBIT has dropped by -$6.01 million (-84.54%).
- GCTK TTM EBIT is now -2331.83% below its all-time high of -$539.10 thousand, reached on March 31, 2011.
Performance
GCTK TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
GCTK EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -60.3% | -34.5% | -84.5% |
| 3 y3 years | -126.8% | -323.9% | -284.0% |
| 5 y5 years | -6.1% | -432.1% | -343.9% |
GCTK EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -78.5% | at low | -249.9% | +27.6% | -229.3% | at low |
| 5 y | 5-year | -126.8% | at low | -436.3% | +27.6% | -358.4% | at low |
| alltime | all time | -507.0% | +31.1% | -554.5% | +56.8% | -2331.8% | at low |
GlucoTrack EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.25 M(-27.6%) | -$13.11 M(+8.5%) |
| Jun 2024 | - | -$4.49 M(+52.2%) | -$12.08 M(+37.8%) |
| Mar 2024 | - | -$2.95 M(+22.1%) | -$8.77 M(+23.5%) |
| Dec 2023 | -$7.10 M(+60.3%) | -$2.42 M(+8.7%) | -$7.10 M(+18.9%) |
| Sep 2023 | - | -$2.22 M(+88.6%) | -$5.97 M(+27.7%) |
| Jun 2023 | - | -$1.18 M(-8.2%) | -$4.68 M(+1.2%) |
| Mar 2023 | - | -$1.28 M(-0.2%) | -$4.62 M(+4.3%) |
| Dec 2022 | -$4.43 M(+11.3%) | -$1.29 M(+38.5%) | -$4.43 M(-3.4%) |
| Sep 2022 | - | -$929.00 K(-17.3%) | -$4.59 M(+3.7%) |
| Jun 2022 | - | -$1.12 M(+2.7%) | -$4.43 M(+6.0%) |
| Mar 2022 | - | -$1.09 M(-24.4%) | -$4.18 M(+4.9%) |
| Dec 2021 | -$3.98 M(+27.1%) | -$1.45 M(+88.4%) | -$3.98 M(+16.6%) |
| Sep 2021 | - | -$767.00 K(-12.1%) | -$3.41 M(-3.4%) |
| Jun 2021 | - | -$873.00 K(-2.6%) | -$3.53 M(+8.0%) |
| Mar 2021 | - | -$896.00 K(+2.1%) | -$3.27 M(+4.5%) |
| Dec 2020 | -$3.13 M(-10.7%) | -$878.00 K(-1.0%) | -$3.13 M(+9.5%) |
| Sep 2020 | - | -$887.00 K(+45.2%) | -$2.86 M(-3.2%) |
| Jun 2020 | - | -$611.00 K(-19.2%) | -$2.95 M(-8.8%) |
| Mar 2020 | - | -$756.00 K(+24.7%) | -$3.24 M(-7.5%) |
| Dec 2019 | -$3.51 M(-47.6%) | -$606.20 K(-38.2%) | -$3.50 M(-17.1%) |
| Sep 2019 | - | -$980.50 K(+9.5%) | -$4.22 M(-12.2%) |
| Jun 2019 | - | -$895.10 K(-12.0%) | -$4.81 M(-18.8%) |
| Mar 2019 | - | -$1.02 M(-23.3%) | -$5.92 M(-12.3%) |
| Dec 2018 | -$6.70 M(-35.0%) | -$1.33 M(-15.4%) | -$6.74 M(-16.4%) |
| Sep 2018 | - | -$1.57 M(-21.9%) | -$8.07 M(-11.1%) |
| Jun 2018 | - | -$2.01 M(+8.8%) | -$9.08 M(-5.6%) |
| Mar 2018 | - | -$1.84 M(-30.4%) | -$9.62 M(-7.3%) |
| Dec 2017 | -$10.30 M | -$2.65 M(+2.8%) | -$10.38 M(+17.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$2.58 M(+1.2%) | -$8.86 M(+14.6%) |
| Jun 2017 | - | -$2.55 M(-1.9%) | -$7.74 M(+14.3%) |
| Mar 2017 | - | -$2.60 M(+128.7%) | -$6.77 M(+25.5%) |
| Dec 2016 | -$5.39 M(-7.4%) | -$1.14 M(-21.6%) | -$5.39 M(-6.9%) |
| Sep 2016 | - | -$1.45 M(-8.4%) | -$5.80 M(+6.5%) |
| Jun 2016 | - | -$1.58 M(+29.3%) | -$5.44 M(-1.4%) |
| Mar 2016 | - | -$1.22 M(-20.4%) | -$5.52 M(-5.3%) |
| Dec 2015 | -$5.83 M(+61.5%) | -$1.54 M(+40.5%) | -$5.83 M(-50.0%) |
| Sep 2015 | - | -$1.10 M(-34.1%) | -$11.64 M(+2.8%) |
| Jun 2015 | - | -$1.66 M(+8.4%) | -$11.33 M(+7.4%) |
| Mar 2015 | - | -$1.53 M(-79.2%) | -$10.55 M(+8.2%) |
| Dec 2014 | -$3.61 M(-63.1%) | -$7.35 M(+840.4%) | -$9.75 M(-1.8%) |
| Sep 2014 | - | -$782.10 K(-11.4%) | -$9.93 M(+0.6%) |
| Jun 2014 | - | -$882.30 K(+20.1%) | -$9.88 M(+0.5%) |
| Mar 2014 | - | -$734.60 K(-90.2%) | -$9.83 M(+0.5%) |
| Dec 2013 | -$9.78 M(+252.6%) | -$7.53 M(+935.5%) | -$9.78 M(+233.5%) |
| Sep 2013 | - | -$727.40 K(-12.6%) | -$2.93 M(+1.4%) |
| Jun 2013 | - | -$831.80 K(+20.9%) | -$2.89 M(+2.8%) |
| Mar 2013 | - | -$687.80 K(+0.3%) | -$2.81 M(+1.4%) |
| Dec 2012 | -$2.77 M(+17.8%) | -$685.50 K(-0.1%) | -$2.77 M(+2.5%) |
| Sep 2012 | - | -$686.00 K(-9.0%) | -$2.71 M(-0.5%) |
| Jun 2012 | - | -$754.10 K(+16.4%) | -$2.72 M(+10.5%) |
| Mar 2012 | - | -$648.00 K(+4.9%) | -$2.46 M(+4.6%) |
| Dec 2011 | -$2.35 M(+69.3%) | -$617.60 K(-11.8%) | -$2.35 M(+35.6%) |
| Sep 2011 | - | -$700.20 K(+41.0%) | -$1.74 M(+67.6%) |
| Jun 2011 | - | -$496.70 K(-7.9%) | -$1.04 M(+92.1%) |
| Mar 2011 | - | -$539.10 K | -$539.10 K |
| Dec 2010 | -$1.39 M(+18.8%) | - | - |
| Dec 2009 | -$1.17 M | - | - |
FAQ
- What is GlucoTrack annual earnings before interest & taxes?
- What is the all time high annual EBIT for GlucoTrack?
- What is GlucoTrack annual EBIT year-on-year change?
- What is GlucoTrack quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for GlucoTrack?
- What is GlucoTrack quarterly EBIT year-on-year change?
- What is GlucoTrack TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for GlucoTrack?
- What is GlucoTrack TTM EBIT year-on-year change?
What is GlucoTrack annual earnings before interest & taxes?
The current annual EBIT of GCTK is -$7.10 M
What is the all time high annual EBIT for GlucoTrack?
GlucoTrack all-time high annual earnings before interest & taxes is -$1.17 M
What is GlucoTrack annual EBIT year-on-year change?
Over the past year, GCTK annual earnings before interest & taxes has changed by -$2.67 M (-60.29%)
What is GlucoTrack quarterly earnings before interest & taxes?
The current quarterly EBIT of GCTK is -$3.25 M
What is the all time high quarterly EBIT for GlucoTrack?
GlucoTrack all-time high quarterly earnings before interest & taxes is -$496.70 K
What is GlucoTrack quarterly EBIT year-on-year change?
Over the past year, GCTK quarterly earnings before interest & taxes has changed by -$834.00 K (-34.51%)
What is GlucoTrack TTM earnings before interest & taxes?
The current TTM EBIT of GCTK is -$13.11 M
What is the all time high TTM EBIT for GlucoTrack?
GlucoTrack all-time high TTM earnings before interest & taxes is -$539.10 K
What is GlucoTrack TTM EBIT year-on-year change?
Over the past year, GCTK TTM earnings before interest & taxes has changed by -$6.01 M (-84.54%)